Thus, we set out to assess PD‐L1 expression on sEVs (sEVs‐PD‐L1+) in HUVECs and to explore its modulation in response to IL‐1β, which is a major player in the immune response and is involved in the pathogenesis of several diseases including cancer [12]. This evidence concerns the gene CD274 and cancer.